{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:13:25Z","timestamp":1791209605853,"version":"4.1.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.ijpharm.2012.08.016","type":"journal-article","created":{"date-parts":[[2012,8,19]],"date-time":"2012-08-19T17:31:28Z","timestamp":1345397488000},"page":"275-276","source":"Crossref","is-referenced-by-count":26,"title":["Cyclosporin nanosphere formulation for ophthalmic administration"],"prefix":"10.1016","volume":"437","author":[{"given":"Wahid","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanir H.","family":"Aldouby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Avramoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham J.","family":"Domb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2012.08.016_bib0005","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jconrel.2011.12.016","article-title":"Cyclosporin pro-dispersion liposphere formulation","volume":"160","author":"Avramoff","year":"2012","journal-title":"J. Control Release"},{"key":"10.1016\/j.ijpharm.2012.08.016_bib0010","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5414\/CPP45126","article-title":"Comparative in vivo bioequivalence and in vitro dissolution of two cyclosporin A soft gelatin capsule formulations","volume":"45","author":"Avramoff","year":"2007","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2012.08.016_bib0015","first-page":"21","article-title":"Restasis use in the chronic dry eye patient","volume":"32","author":"Bataoel","year":"2007","journal-title":"Insight"},{"key":"10.1016\/j.ijpharm.2012.08.016_bib0020","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00347-005-1300-9","article-title":"Current treatment for dry eye syndrome","volume":"103","author":"Cursiefen","year":"2006","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.ijpharm.2012.08.016_bib0025","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.drudis.2006.07.015","article-title":"Disease, destination, dose and delivery aspects of ciclosporin: the state of the art","volume":"11","author":"Italia","year":"2006","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijpharm.2012.08.016_bib0030","first-page":"S88","article-title":"Management of dry eye disease","volume":"14","author":"Lemp","year":"2008","journal-title":"Am. J. Manage. Care"},{"key":"10.1016\/j.ijpharm.2012.08.016_bib0035","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/ICO.0b013e318074e460","article-title":"Comparison of topical cyclosporine, punctal occlusion, and a combination for the treatment of dry eye","volume":"26","author":"Roberts","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.ijpharm.2012.08.016_bib0040","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1600-0684.2009.00364.x","article-title":"Restasis for the treatment of \u2018dry eye\u2019 in Aotus nancymaae","volume":"38","author":"Schuler","year":"2009","journal-title":"J. Med. Primatol."},{"key":"10.1016\/j.ijpharm.2012.08.016_bib0045","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000131073","article-title":"Medical management of dry eye disease","volume":"41","author":"Tuft","year":"2008","journal-title":"Dev. Ophthalmol."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312008113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312008113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T10:55:12Z","timestamp":1542797712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517312008113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":9,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0378517312008113"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2012.08.016","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}